New Research Results at the Rotterdam Microbiome R&D & Business Collaboration Forum Europe

New Research Results at the Rotterdam 
Microbiome R&D & Business Collaboration Forum Europe

Microbiotic ingredients contained in many healthcare products

Berlin / Rotterdam, 14. October 2021 – At the "9th Microbiome & Probiotics R&D and Business Collaboration Forum", held 26 and 27 October at the Postillion Convention Centre in Rotterdam, BELANO medical AG will present current microbiome research results. Professor Dr. Christine Lang, Professor of Microbiology at the Technical University of Berlin and Chief Scientific Officer at BELANO medical AG, will outline how research into the microbiome evolved in recent years, how it is currently progressing, and which microbiotic, biological ingredients will result.

The tremendous impact of bacterial diversity – among others in the skin and gut floras – on human health has been known for quite some time. "Once the microbiome becomes unbalanced, a number of acute and chronic diseases may emerge", Professor Lang explained in the run-up to the event. "Possible are skin diseases, for instance atopic eczema or rosacea, or gastrointestinal disorders, or even signs of psychological or neurological disorders such as autism." In recent years, numerous studies at universities and research institutes have demonstrated links between diet and gut flora on the one hand, and the consequences for, e.g., skin texture or psychological wellbeing on the other (see, among others, https://www.gesunde-bakterien.de/en/the-link-between-gut-bacteria-and-autism/).

BELANO medical identified probiotic agents which have a particularly positive effect on human health and on the microbiomes inside and on the human body. These patented agents are based on natural lactic acid bacteria, and find use in BELANO medical's certified medical products, e.g. "salvans" throat lozenges or the "ibiotics" range of cosmetics, as well as the "ibiotics med" medical skincare product line.

In addition, these ingredients are available as inputs, or as ready-made formulations (bulk ware) for businesses and corporations in the pharmaceutical and cosmetics industries, or branded companies launching their own product lines (private label). Many internationally known brand-name cosmetics or skincare products contain BELANO medical's active ingredients.

Apart from the presentation by Professor Christine Lang, BELANO medical will also highlight how naturally extracted ingredients affect the microbiome and present its B2B and B2C product portfolios. Development and manufacturing are done in Germany and do not involve animal testing or animal inputs.

For further information, please see https://www.global-engage.com/event/microbiota/.

About BELANO medical AG:
BELANO medical AG is a biotechnology company which leverages the findings of its research into beneficial microorganisms for pharmaceutical and care products. The company develops and launches novel approaches to medical skin care, disease prevention, and the support of healing processes with the aim of creating new therapeutic options for diseases and indications which currently cannot be treated satisfactorily. BELANO’s mission is to make its patented agents and products available to everyone. To do so, the company relies on national and international collaborations with distributors and larger partners such as Henkel AG or the Müller chain of retail stores.

For further information:
BELANO medical AG
Neuendorfstraße 19
D-16761 Hennigsdorf (Berlin), Germany
Phone: +49 (0)3302 86 37 995
info@belanomedical.com
www.belanomedical.com